Wednesday, September 2, 2026

Pharmacy School, City Partnership Provides Free Flu Shots to Angelenos

The USC School of Pharmacy has partnered with the City of Los Angeles to provide free flu vaccinations at various COVID-19 testing locations across the city.

Watch: Using AI to protect air passengers in a pandemic

The COVID-19 pandemic has created an unparalleled crisis for the airline industry: International and domestic air travel has slowed considerably...

Online farmers’ markets valuable when crisis events like COVID occur

New research is shining light on the importance of farmers' markets’ ability to mitigate potential disruptions to distribution networks in the face of system shocks like the COVID-19 pandemic.

National clinical trial to treat hospitalised patients with COVID-19

A new clinical trial led by the University of Warwick and Queen’s University Belfast seeks to find alternatives to ventilators to treat patients who are critically ill with COVID-19.

Navigating the next phase of COVID-19: three critical issues for business leaders

Business leaders need to address questions on work processes, performance and virtual teams to improve productivity and engagement through the COVID-19 induced recession, says UNSW Business School.

Coronavirus antibodies last at least three months after infection, University of Toronto study finds

Coronavirus antibodies can last at least three months after a person becomes infected with the virus that causes COVID-19, according to a study published in Science Immunology.

Priorities post-COVID-19 outlined at Tourism Policy School

Tourism Minister Stuart Nash says planning is underway for a new-look tourism sector post the COVID-19 vaccination programme and when international borders re-open.

New Zealand is right to pause travel to Australia. It buys time to upgrade...

With the trans-Tasman travel bubble burst, now is the time to upgrade our Covid response against the threat of a Delta variant outbreak. Read more from University of Canterbury's Dr Matt Hobbs in a new article on The Conversation.

New research-backed tools ready to support parents in navigating COVID-19 pandemic

Researchers at the University of Alberta have developed a series of new information tools to help parents with questions about their children and COVID-19.

Oxford coronavirus vaccine produces strong immune response in older adults

The ChAdOx1 nCov-2019 coronavirus vaccine, developed by teams at the University of Oxford, has been shown to trigger a robust immune response in healthy adults aged 56-69 and those over 70 years of age.
- Advertisement -